Rolf Burghaus
0000-0001-7843-427X
Publication & Citation Trends
Publications
0 total
Harnessing Open‐Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference
Cited by 0
Semantic Scholar
Polycystic ovary syndrome and elevated body mass index independently increase type 2 diabetes risk with obesity-mediated risk dominating: a real-world data analysis of US patients.
Cited by 1
Semantic Scholar
In‐Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community OA
Cited by 8
Semantic Scholar
Applied physiologically‐based pharmacokinetic modeling to assess uridine diphosphate‐glucuronosyltransferase‐mediated drug–drug interactions for Vericiguat OA
Cited by 5
Semantic Scholar
Opportunities and Challenges for AI-Based Analysis of RWD in Pharmaceutical R&D: A Practical Perspective OA
Cited by 7
Semantic Scholar
Meta-analysis of preclinical measures of efficacy in immune checkpoint blockade therapies and comparison to clinical efficacy estimates OA
Cited by 2
Semantic Scholar
Model‐informed approach to support pediatric dosing for the pan‐PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors OA
Cited by 2
Semantic Scholar
Data-driven identification of heart failure disease states and progression pathways using electronic health records OA
Cited by 18
Semantic Scholar
Research Topics
Pharmacogenetics and Drug Metabolism
(8)
nanoparticles nucleation surface interactions
(6)
Pharmaceutical studies and practices
(6)
Statistical Methods in Clinical Trials
(5)
Atrial Fibrillation Management and Outcomes
(4)
Affiliations
Roche (Switzerland)
University of Florida
Columbus Oncology and Hematology Associates
Heinrich Heine University Düsseldorf
Bayer (Germany)